Home/Filings/4/0001104659-22-092960
4//SEC Filing

Ellis Christopher 4

Accession 0001104659-22-092960

CIK 0001828185other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:06 PM ET

Size

15.2 KB

Accession

0001104659-22-092960

Insider Transaction Report

Form 4
Period: 2022-08-17
Ellis Christopher
Chief Operating Officer
Transactions
  • Sale

    Ordinary Shares

    2022-08-17$4.77/sh649$3,09375 total
  • Exercise/Conversion

    Share Option (Right to Buy)

    2022-08-1764942,781 total
    Exercise: $0.00Exp: 2028-02-16Ordinary Shares (649 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    2022-08-182,17540,606 total
    Exercise: $0.00Exp: 2028-02-16Ordinary Shares (2,175 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2022-08-17$0.00/sh+649$0724 total
  • Exercise/Conversion

    Ordinary Shares

    2022-08-18$0.00/sh+2,175$12,250 total
  • Sale

    Ordinary Shares

    2022-08-18$4.84/sh2,175$10,53175 total
Footnotes (4)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.18 - $4.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.

Issuer

Vaccitech plc

CIK 0001828185

Entity typeother

Related Parties

1
  • filerCIK 0001851664

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:06 PM ET
Size
15.2 KB